CN107455759A - 一种海参营养保健粥 - Google Patents
一种海参营养保健粥 Download PDFInfo
- Publication number
- CN107455759A CN107455759A CN201710871658.3A CN201710871658A CN107455759A CN 107455759 A CN107455759 A CN 107455759A CN 201710871658 A CN201710871658 A CN 201710871658A CN 107455759 A CN107455759 A CN 107455759A
- Authority
- CN
- China
- Prior art keywords
- parts
- sea cucumber
- powder
- ginseng
- grape pip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 70
- 230000036541 health Effects 0.000 title claims abstract description 16
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 35
- 240000008042 Zea mays Species 0.000 claims abstract description 24
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 24
- 241000208340 Araliaceae Species 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 23
- 235000005822 corn Nutrition 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 22
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 22
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 22
- 102000008186 Collagen Human genes 0.000 claims abstract description 21
- 108010035532 Collagen Proteins 0.000 claims abstract description 21
- 229920001436 collagen Polymers 0.000 claims abstract description 21
- 235000021323 fish oil Nutrition 0.000 claims abstract description 21
- 235000013312 flour Nutrition 0.000 claims abstract description 21
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 17
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 17
- 235000012661 lycopene Nutrition 0.000 claims abstract description 17
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 17
- 229960004999 lycopene Drugs 0.000 claims abstract description 17
- 239000001751 lycopene Substances 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 241000219095 Vitis Species 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 210000000936 intestine Anatomy 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 210000001835 viscera Anatomy 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241000965254 Apostichopus japonicus Species 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 238000000498 ball milling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 2
- 210000004700 fetal blood Anatomy 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000009469 supplementation Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 240000006365 Vitis vinifera Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 18
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 17
- 241000229143 Hippophae Species 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- -1 still Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical group C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 208000001936 exophthalmos Diseases 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及中药保健品技术领域,具体地说是一种海参营养保健粥,其特征在于该制剂由海参胶原蛋白、VC、VE、葡萄籽PE、番茄红素、人参、玉米粉、牡蛎粉、鱼油组成,上述各种成分的重量份为海参胶原蛋白10‑15粉、VC2‑3份、VE2‑3份、葡萄籽PE5‑6份、番茄红素1‑3份、人参1‑3份、玉米粉15‑30份、牡蛎粉11‑20份、鱼油4‑6份,具有配方合理,增强免疫力、提高记忆力、营养补充合理等优点。
Description
技术领域
本发明涉及中药保健品技术领域,具体地说是一种配方合理,增强免疫力、提高记忆力、营养补充合理的海参营养保健粥。
背景技术
随着国民经济的发展,各种学生用保健品营运而生,学生在学习的过程中,最重要的就是提高记忆力并能补充营养,特别是高中学生,学习任务越来越繁重,压力大,大部分学生都会出现头痛、头昏、失眠、上课注意力不集中,甚至控制不住自己打瞌睡,记忆力明显减退,严重影响学习成绩,为了解决这种问题,目前市面上出现了众多针对学生提高记忆力的药品,但是,药物对人体会产生副作用,并不适用于学生来食用。
发明内容
本发明的目的是解决上述现有技术的不足,提供一种配方合理,增强免疫力、提高记忆力、营养补充合理的海参营养保健粥。
本发明解决其技术问题所采用的技术方案是:
一种海参营养保健粥,其特征在于该制剂由海参胶原蛋白、VC、VE、葡萄籽PE、番茄红素、人参、玉米粉、牡蛎粉、鱼油组成,上述各种成分的重量份为海参胶原蛋白10-15粉、VC2-3份、VE2-3份、葡萄籽PE5-6份、番茄红素1-3份、人参1-3份、玉米粉15-30份、牡蛎粉11-20份、鱼油4-6份。
本发明所述的各种成分中最优化的重量份为:海参胶原蛋白11粉、VC2份、VE3份、葡萄籽PE5份、番茄红素1份、人参2份、玉米粉22份、牡蛎粉15份、鱼油6份。
一种海参营养保健粥的制备工艺,其特征在于所述的制备工艺步骤为:
(一)海参胶原蛋白粉(海参速溶粉)双酶降解的加工工艺:
步骤A:首先将从大海捞出的新鲜刺海参,洗净、剪开。除去内脏。保留流出来的液体它含有海参的酶、并将海参内脏中的海参肠和海参花中的杂质除净,海参肠和海参花一并应用;
步骤B:将海参皮(包括海参肠和海参花)粉碎后球磨打浆,加入酶解罐中,加适量的水(为海参皮重的5—10倍);
步骤C:加入海参本身含有的酶和风味酶适量,混合均匀,打开蒸汽开关,渐渐升温至45—65度,在不断搅拌的条件下,维持恒温3.5---4小时;
步骤D灭酶:待整,升温至100度,5—10分钟,降温后,过滤;
步骤E:将以上液体,调整浓度。用洁净喷干塔,进行喷雾干燥;
步骤F:喷干粉检验合格,塑料袋抽真空包装,低温保存,备用;
(二)番茄红素的制备:
步骤G:取有资质的厂家生产的番茄红原料呈暗红色粉末,连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;
步骤H:JYL-5破壁料理机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,用处理洁净的不锈钢粉碎机、粉碎过筛达100目;
步骤I:密封包装后,备用;
(三)葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的制备:
步骤S:取有资质的厂家生产的葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的原料粉末连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;
步骤T:经检验合格的VC、VE分别置真空干燥机干燥后,用处理洁净的不锈钢粉碎机、分别粉碎过筛达100目。密封包装后,备用。
葡萄籽提取粉、人参粉这六种粉分别用九阳破壁机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,分别用处理洁净的不锈钢粉碎机,进行粉碎。粉末达200目,分别包装备用。
(四)成品的制备:
步骤U:配料比例,准确称取经检验合格的各种原料,置于三维混合机中,开机混合30分钟;
步骤V:最后将鱼油加入上述混合粉中。
步骤Y:在制备完成后进行冲水制作粥品即可。
本发明由于该制剂由海参胶原蛋白、VC、VE、葡萄籽PE、番茄红素、人参、玉米粉、牡蛎粉、鱼油组成,具有配方合理,增强免疫力、提高记忆力、营养补充合理等优点。
具体实施方式
一种海参营养保健粥,其特征在于该制剂由海参胶原蛋白、VC、VE、葡萄籽PE、番茄红素、人参、玉米粉、牡蛎粉、鱼油组成,上述各种成分的重量份为海参胶原蛋白10-15粉、VC2-3份、VE2-3份、葡萄籽PE5-6份、番茄红素1-3份、人参1-3份、玉米粉15-30份、牡蛎粉11-20份、鱼油4-6份,所述的各种成分中最优化的重量份为:海参胶原蛋白11粉、VC2份、VE3份、葡萄籽PE5份、番茄红素1份、人参2份、玉米粉22份、牡蛎粉15份、鱼油6份,其制备工艺步骤为:(一)海参胶原蛋白粉(海参速溶粉)双酶降解的加工工艺:步骤A:首先将从大海捞出的新鲜刺海参,洗净、剪开。除去内脏。保留流出来的液体它含有海参的酶、并将海参内脏中的海参肠和海参花中的杂质除净,海参肠和海参花一并应用;步骤B:将海参皮(包括海参肠和海参花)粉碎后球磨打浆,加入酶解罐中,加适量的水(为海参皮重的5—10倍);步骤C:加入海参本身含有的酶和风味酶适量,混合均匀,打开蒸汽开关,渐渐升温至45—65度,在不断搅拌的条件下,维持恒温3.5---4小时;步骤D灭酶:待整,升温至100度,5—10分钟,降温后,过滤;步骤E:将以上液体,调整浓度。用洁净喷干塔,进行喷雾干燥;步骤F:喷干粉检验合格,塑料袋抽真空包装,低温保存,备用,(二)番茄红素的制备:步骤G:取有资质的厂家生产的番茄红原料呈暗红色粉末,连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;步骤H:JYL-5破壁料理机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,用处理洁净的不锈钢粉碎机、粉碎过筛达100目;步骤I:密封包装后,备用;(三)葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的制备:步骤S:取有资质的厂家生产的葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的原料粉末连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;步骤T:经检验合格的VC、VE分别置真空干燥机干燥后,用处理洁净的不锈钢粉碎机、分别粉碎过筛达100目。密封包装后,备用。葡萄籽提取粉、人参粉这六种粉分别用九阳破壁机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,分别用处理洁净的不锈钢粉碎机,进行粉碎。粉末达200目,分别包装备用,(四)成品的制备:步骤U:配料比例,准确称取经检验合格的各种原料,置于三维混合机中,开机混合30分钟;步骤V:最后将鱼油加入上述混合粉中,步骤Y:在制备完成后进行冲水制作粥品即可。
本发明中的成分分析
海参胶原蛋白:海参,味甘咸,补肾,益精髓,摄小便,壮阳疗痿,其性温补,足敌人参,故名海参;海参具有提高记忆力、延缓性腺衰老,防止动脉硬化以及抗肿瘤等作用。
沙棘提取物:功效有防治心脑血管疾病:从沙棘中提取的沙棘总黄酮、不饱和脂肪酸等成分能有效调节血压、血脂、血糖,直接清除超氧自由基和羟自由基,降低血液黏度,抑制血小板过度聚集、软化血管、改善血液循环、防止动脉硬化,对冠心病、心绞痛、心肌梗塞、心律失常、心肌缺血缺氧等病症有极好的防治作用,另外对改善心功能、缓解胸闷、心悸、气短等症状也有极好的作用;辅助治疗糖尿病,从沙棘中提取的有效成分(沙棘黄酮、维生素、矿物质、微量元素、SOD等)能降低血糖、稳定糖尿病的病情;增强人体免疫功能,沙棘中含有大量的维生素C、维生素E、类胡萝卜素、SOD、沙棘黄酮都具有很强的抗氧化作用。对体液免疫和细胞免疫具有明显的调节作用,还有一定的抗过敏作用、增强人体抗病能力,这些有效成分能清除人体自由基,提高机体免疫功能作用,因而临床对多种免疫系统疾病如免疫功能低下等有很好作用。另外沙棘黄酮海可调节甲状腺功能,使甲状腺功能亢进恢复正常;抗肿瘤、抗癌作用;沙棘中的生物活性成分白花青素、苦木素、香豆素、5-羟色胺、β胡萝卜素等具有明显的抗氧作用。对人体内的癌细胞具有一定的抑制及杀伤作用,还具有阻断致癌因素的作用。而且可以通过提高癌症患者的自身免疫功能,增强人体对癌症的抵抗能力,特别对胃癌、食道癌、直肠癌、肝癌等消化系统的癌症效果相当明显。另外能减轻放疗及化疗的毒副作用,促进癌症患者康复;防治呼吸系统疾病,沙棘在传统医学理论中就具有止咳平喘、利肺化痰的作用,对慢性咽炎、支气管炎、咽喉肿痛、哮喘、咳嗽多痰等呼吸道系统疾病均有很好作用;保肝护肝,防治肝脏疾病,沙棘中含有的苹果酸、草酸等有机酸具有缓解抗生素和其他药物的毒性作用,促进受损的干细胞加快愈合,降低转氨酶,保护肝脏。同时对肝脏对于的脂肪有消除作用。对急性肝病、慢性肝病、酒精肝、脂肪肝、肝硬化有明显的缓解作用。另外,沙棘油的对肾脏及骨髓均有明显的保护作用;防治消化系统疾病,由于沙棘中含有大量氨基酸、有机酸等多种营养成分,可以促进胃酸、胃液分泌、因而沙棘具有消食化滞、健脾养胃、疏肝理气的作用。对于消化不良、腹胀痛、胃炎、胃及十二指肠溃疡、肠炎、慢性便秘等均有极好的作用;防治眼科疾病,沙棘中含有无羟色胺具有很强的抗辐射作用。原苏联把沙棘油列入宇航员的必须保健品。对防治各类眼科疾病具有显著效果。用它可治疗沙眼、眼球突出性甲状腺肿、角膜炎、水泡、眼皮烧伤和结膜炎等;止血镇痛、消炎消肿、化腐生肌治疗各种妇科疾病,沙棘中提取的沙棘油富含VE、胡萝卜素、类胡萝卜素、β-谷甾醇、不饱和脂肪酸等,可促进机体新陈代谢,有利于损伤的组织恢复,增强炎症中心的抗炎作用,以及明显的促进溃疡愈合作用。因而沙棘油在临床上对辐射损伤、烧伤、烫伤、皮炎、粘膜炎、口腔溃疡、子宫内膜炎、宫颈糜烂和胃及痛、减少不良反应,也有很好作用;健脑益智、美容护肤、抗衰老,沙棘中含有的多种氨基酸、多种维生素、微量元素、不饱和脂肪酸、SOD等,对防止皮肤老化、淡化老年斑、黄褐斑、改善睡眠质量、提高记忆力、保持旺盛的精力和体力均有良好的作用。
VC:维生素C又称抗坏血酸,维生素C为抗体及胶原形成,组织修补(包括某些氧化还原作用),苯丙氨酸、酪氨酸、叶酸的代谢,铁、碳水化合物的利用,脂肪、蛋白质的合成,维持免疫功能,羟化与羟色胺,保持血管的完整,促进非血红素铁吸收等所必需,同时维生素C还具备有抗氧化,抗自由基,抑制酪氨酸酶的形成。
VE:延缓衰老,有效减少皱纹的产生,保持青春的容貌;减少细胞耗氧量,使人更有耐久力,有助减轻腿抽筋和手足僵硬的状况;抗氧化保护机体细胞免受自由基的毒害;改善脂质代谢,预防冠心病、动脉粥样硬化;预防癌症,有效抑制肿瘤生长;预防多处慢性疾病;预防炎症性皮肤病、脱发症;预防溶血性贫血、保护红血球使之不容易破裂;预防治疗甲状腺疾病;改善血液循环、保护组织、降低胆固醇、预防高血压。
番茄红素:是植物中所含的一种天然色素。主要存在于茄科植物西红柿的成熟果实中。它是目前在自然界的植物中被发现的最强抗氧化剂之一。科学证明,人体内的单线态氧和氧自由基是侵害人体自身免疫系统的罪魁祸首。番茄红素清除自由基的功效远胜于其他类胡萝卜素和维生素E,其淬灭单线态氧速率常数是维生素E的100倍。它可以有效的防治因衰老,免疫力下降引起的各种疾病。
人参:性味,味甘、微苦,性温、平。归脾、肺经、心经。补气,固脱,生津,安神,益智,体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之。
玉米粉:玉米面含有丰富的营养素。在美国和其他一些发达国家,玉米已被列为谷类食物中的首位保健食品,被称为"黄金作物"。经研究发现玉米中含有大量的卵磷脂、亚油酸、谷物醇、维生素E、纤维素等,具有降血压、降血脂、抗动脉硬化、预防肠癌、美容养颜、延缓衰老等多种保健功效,也是糖尿病人的适宜佳品。
牡蛎粉:性味归经:咸,微寒。归肝、胆、肾经。功能:平肝息风药;养阴药。煅牡蛎:收敛固涩除酸的作用强,治疗胃疼、胃酸等。生牡蛎:上收下敛,治疗头晕、便稀,提高记忆力。
鱼油的作用:1、调节血脂降低血液中低密度脂蛋白、胆固醇和甘油三酯的含量,提高对人体有益的高密度脂蛋白含量,促进体内饱和脂肪酸的代谢,防止脂肪垃圾在血管壁内堆积。2、保心护脑有效控制人体血脂浓度,预防心脑血管疾病。3、清理血栓降低血液粘稠度,预防血栓形成,预防脑血栓和脑梗塞。4、调节血压缓解血管紧张,防止血管痉挛,降低血压。5、预防动脉硬化增强血管的弹性和韧性,抑制动脉粥样硬化的形成和发展。6、补脑健脑,提高记忆力促进脑细胞充分发育,防止智力下降、健忘、老年痴呆等。7、缓解眼疲劳,保护视力在大脑和视网膜等组织中DHA含量很高,鱼油中含DHA可减少眼部患病的几率,减轻眼睛疲劳。8、增强免疫力在其他发达国家鱼油被用来辅助治疗糖尿病、高血压、类风湿关节炎及系统性疾病。
实施例1
海参胶原蛋白11粉、VC2份、VE3份、葡萄籽PE5份、番茄红素1份、人参2份、玉米粉22份、牡蛎粉15份、鱼油6份。
实施例2
海参胶原蛋白15粉、VC3份、VE3份、葡萄籽PE6份、番茄红素3份、人参3份、玉米粉30份、牡蛎粉20份、鱼油5份。。
实施例3
海参胶原蛋白10粉、VC2份、VE2份、葡萄籽PE2份、番茄红素2份、人参2份、玉米粉25份、牡蛎粉15份、鱼油5份。。
实施例4
海参胶原蛋白13粉、VC2份、VE2份、葡萄籽PE5份、番茄红素1份、人参1份、玉米粉24份、牡蛎粉14份、鱼油6份。。
实施例5
海参胶原蛋白11粉、VC2份、VE3份、葡萄籽PE5份、番茄红素2份、人参3份、玉米粉19份、牡蛎粉17份、鱼油6份。
Claims (3)
1.一种海参营养保健粥,其特征在于该制剂由海参胶原蛋白、VC、VE、葡萄籽PE、番茄红素、人参、玉米粉、牡蛎粉、鱼油组成,上述各种成分的重量份为海参胶原蛋白10-15粉、VC2-3份、VE2-3份、葡萄籽PE5-6份、番茄红素1-3份、人参1-3份、玉米粉15-30份、牡蛎粉11-20份、鱼油4-6份。
2.根据权利要求1所述的一种海参营养保健粥,其特征在于所述的各种成分中最优化的重量份为:海参胶原蛋白11粉、VC2份、VE3份、葡萄籽PE5份、番茄红素1份、人参2份、玉米粉22份、牡蛎粉15份、鱼油6份。
3.一种海参营养保健粥的制备工艺,其特征在于所述的制备工艺步骤为:
(一)海参胶原蛋白粉(海参速溶粉)双酶降解的加工工艺:
步骤A:首先将从大海捞出的新鲜刺海参,洗净、剪开。除去内脏。保留流出来的液体它含有海参的酶、并将海参内脏中的海参肠和海参花中的杂质除净,海参肠和海参花一并应用;
步骤B:将海参皮(包括海参肠和海参花)粉碎后球磨打浆,加入酶解罐中,加适量的水(为海参皮重的5—10倍);
步骤C:加入海参本身含有的酶和风味酶适量,混合均匀,打开蒸汽开关,渐渐升温至45—65度,在不断搅拌的条件下,维持恒温3.5---4小时;
步骤D灭酶:待整,升温至100度,5—10分钟,降温后,过滤;
步骤E:将以上液体,调整浓度。用洁净喷干塔,进行喷雾干燥;
步骤F:喷干粉检验合格,塑料袋抽真空包装,低温保存,备用;
(二)番茄红素的制备:
步骤G:取有资质的厂家生产的番茄红原料呈暗红色粉末,连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;
步骤H:JYL-5破壁料理机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,用处理洁净的不锈钢粉碎机、粉碎过筛达100目;
步骤I:密封包装后,备用;
(三)葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的制备:
步骤S:取有资质的厂家生产的葡萄籽提取粉、VC、VE、人参、玉米粉、牡蛎粉的原料粉末连同厂家的检验连同厂家的检验报告送检测中心检验确定合格;
步骤T:经检验合格的VC、VE分别置真空干燥机干燥后,用处理洁净的不锈钢粉碎机、分别粉碎过筛达100目。密封包装后,备用。
葡萄籽提取粉、人参粉这六种粉分别用九阳破壁机进行破壁处理,用压力0.09MP温度控制在40度,ORW105微波真空干燥机干燥后,分别用处理洁净的不锈钢粉碎机,进行粉碎。粉末达200目,分别包装备用。
(四)成品的制备:
步骤U:配料比例,准确称取经检验合格的各种原料,置于三维混合机中,开机混合30分钟;
步骤V:最后将鱼油加入上述混合粉中。
步骤Y:在制备完成后进行冲水制作粥品即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710871658.3A CN107455759A (zh) | 2017-09-25 | 2017-09-25 | 一种海参营养保健粥 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710871658.3A CN107455759A (zh) | 2017-09-25 | 2017-09-25 | 一种海参营养保健粥 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107455759A true CN107455759A (zh) | 2017-12-12 |
Family
ID=60553037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710871658.3A Withdrawn CN107455759A (zh) | 2017-09-25 | 2017-09-25 | 一种海参营养保健粥 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107455759A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105725201A (zh) * | 2016-03-01 | 2016-07-06 | 陈键 | 一种提高儿童免疫力的营养粉及其制备方法 |
CN106666464A (zh) * | 2015-11-10 | 2017-05-17 | 尤世元 | 一种海参营养粉的制备方法 |
CN106723068A (zh) * | 2016-11-14 | 2017-05-31 | 威海力元海洋生物科技有限公司 | 一种海参番茄红素硒抗辐射胶囊配方及其制备工艺 |
-
2017
- 2017-09-25 CN CN201710871658.3A patent/CN107455759A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106666464A (zh) * | 2015-11-10 | 2017-05-17 | 尤世元 | 一种海参营养粉的制备方法 |
CN105725201A (zh) * | 2016-03-01 | 2016-07-06 | 陈键 | 一种提高儿童免疫力的营养粉及其制备方法 |
CN106723068A (zh) * | 2016-11-14 | 2017-05-31 | 威海力元海洋生物科技有限公司 | 一种海参番茄红素硒抗辐射胶囊配方及其制备工艺 |
Non-Patent Citations (5)
Title |
---|
江省蓉等: "《图解保健食品全书》", 31 May 2015, 湖南科学技术出版社 * |
潘小梅: "《高血压这样吃最好》", 31 May 2013, 中国中医药出版社 * |
潘道东等: "《功能性食品添加剂》", 31 January 2006, 中国轻工业出版社 * |
王剑: "《美味滋补家常菜谱》", 31 July 1998, 上海科学技术文献出版社 * |
郑伟达等: "《防癌抗癌食疗金方》", 31 January 2016, 中国医药科技出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989165B (zh) | 一种刺梨复合维生素c片及其制备方法 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN106173733A (zh) | 一种黑木耳养生保健饮料及其制备方法 | |
CN105581327B (zh) | 一种无添加剂含木耳养发乌发健康食品及其生产方法 | |
CN106616943B (zh) | 一种即食黑木耳营养糊及其制备方法 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN105614667A (zh) | 一种养心富硒米粉及其制备方法 | |
CN104799358A (zh) | 一种风味花生酱的生产方法 | |
CN104921133A (zh) | 一种女性谷菜果营养食品及其制备方法 | |
CN104323391B (zh) | 一种植物保健固体饮料及其制备方法 | |
CN109275856A (zh) | 一种灵芝食品 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN105212040A (zh) | 一种含黑玉米的复合营养粉及其制备方法 | |
CN107574215A (zh) | 一种松花粉活性肽的制备方法 | |
CN112273490A (zh) | 山楂生姜茶饮剂 | |
CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
CN107455759A (zh) | 一种海参营养保健粥 | |
CN101485813B (zh) | 美容软胶囊及其制备方法 | |
CN102018160A (zh) | 一种冬瓜复合食用粉 | |
CN105410926A (zh) | 一种长茎葡萄蕨藻减肥胶囊及其制备方法 | |
CN111296736A (zh) | 椰粉核桃燕麦粥 | |
CN103734727A (zh) | 一种阿胶海参及其制备方法 | |
CN104187264B (zh) | 一种提高人体免疫力的营养组合物及其制备方法 | |
CN103815357A (zh) | 竹荪清热利湿火锅调料及其生产方法 | |
CN108669434A (zh) | 妇女补虚养颜浆及加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20171212 |